Review
doi: 10.1159/000101311.
Epithelial-mesenchymal transition in prostate cancer and the potential role of kallikrein serine proteases
Affiliations
- PMID: 17587816
- DOI: 10.1159/000101311
Item in Clipboard
Review
Epithelial-mesenchymal transition in prostate cancer and the potential role of kallikrein serine proteases
Cells Tissues Organs.
2007.
Abstract
Prostate cancer is associated with significant mortality once the tumour has spread outside the gland. Epithelial-mesenchymal transition (EMT) has been proposed to facilitate this dissemination of tumour cells. In this article we summarize the evidence for EMT in prostate cancer, drawing on the expression of EMT-related markers and the functions of factors known to induce EMT in other systems. We also discuss our recent findings that two members of the tissue kallikrein family of serine proteases, prostate-specific antigen (PSA/KLK3) and kallikrein-related peptidase 4 (KLK4), lead to EMT-like changes in PC3 prostate cancer cells.
2007 S. Karger AG, Basel
Similar articles
-
Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells.Endocr Relat Cancer. 2005 Sep;12(3):631-43. doi: 10.1677/erc.1.00958. Endocr Relat Cancer. 2005. PMID: 16172196
-
The role of kallikrein-related peptidases in prostate cancer: potential involvement in an epithelial to mesenchymal transition.Biol Chem. 2006 Jun;387(6):707-14. doi: 10.1515/BC.2006.089. Biol Chem. 2006. PMID: 16800731 Review.
-
Seminal fluid characterization for male fertility and prostate cancer: kallikrein-related serine proteases and whole proteome approaches.Semin Thromb Hemost. 2007 Feb;33(1):87-99. doi: 10.1055/s-2006-958467. Semin Thromb Hemost. 2007. PMID: 17253195 Review.
-
Human kallikrein 7 induces epithelial-mesenchymal transition-like changes in prostate carcinoma cells: a role in prostate cancer invasion and progression.Anticancer Res. 2010 Sep;30(9):3413-20. Anticancer Res. 2010. PMID: 20944116
-
Substrates of the prostate-specific serine protease prostase/KLK4 defined by positional-scanning peptide libraries.Prostate. 2005 Jan 1;62(1):1-13. doi: 10.1002/pros.20101. Prostate. 2005. PMID: 15389820
Cited by
-
Enrichment of the Cancer Stem Phenotype in Sphere Cultures of Prostate Cancer Cell Lines Occurs through Activation of Developmental Pathways Mediated by the Transcriptional Regulator ΔNp63α.PLoS One. 2015 Jun 25;10(6):e0130118. doi: 10.1371/journal.pone.0130118. eCollection 2015. PLoS One. 2015. PMID: 26110651 Free PMC article.
-
Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs).Biochimie. 2010 Nov;92(11):1546-67. doi: 10.1016/j.biochi.2010.06.022. Epub 2010 Jul 6. Biochimie. 2010. PMID: 20615447 Free PMC article. Review.
-
Molecular pathways involved in prostate carcinogenesis: insights from public microarray datasets.PLoS One. 2012;7(11):e49831. doi: 10.1371/journal.pone.0049831. Epub 2012 Nov 20. PLoS One. 2012. PMID: 23185449 Free PMC article.
-
Diversity of Epithelial-Mesenchymal Phenotypes in Circulating Tumour Cells from Prostate Cancer Patient-Derived Xenograft Models.Cancers (Basel). 2021 Jun 1;13(11):2750. doi: 10.3390/cancers13112750. Cancers (Basel). 2021. PMID: 34206049 Free PMC article.
-
Overexpression of myosin VI in prostate cancer cells enhances PSA and VEGF secretion, but has no effect on endocytosis.Oncogene. 2010 Jan 14;29(2):188-200. doi: 10.1038/onc.2009.328. Epub 2009 Oct 26. Oncogene. 2010. PMID: 19855435 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
